Canlyniadau Chwilio - Shilpi Arora
- Dangos 1 - 6 canlyniadau o 6
-
1
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer gan David O. Azorsa, Irma M. Gonzales, Gargi D. Basu, Ashish Choudhary, Shilpi Arora, Kristen Bisanz, Jeffrey Kiefer, Meredith C. Henderson, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses
Cyhoeddwyd 2009Artigo -
2
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes gan John P. McGrath, Kaylyn E. Williamson, Srividya Balasubramanian, Shobu Odate, Shilpi Arora, Charlie Hatton, Thomas M. Edwards, Thomas O’Brien, Steven Magnuson, David Stokoe, Danette L. Daniels, Barbara M. Bryant, Patrick Trojer
Cyhoeddwyd 2016Artigo -
3
RNAi screening of the kinome with cytarabine in leukemias gan Raoul Tibes, James M. Bogenberger, Leena Chaudhuri, R. Tanner Hagelstrom, Donald Chow, Megan Buechel, Irma M. Gonzales, Tim Demuth, James L. Slack, Ruben A. Mesa, Esteban Braggio, Hongwei Yin, Shilpi Arora, David O. Azorsa
Cyhoeddwyd 2012Artigo -
4
MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration gan Shilpi Arora, Aarati R. Ranade, Nhan L. Tran, Sara Nasser, Shravan Sridhar, Ronald L. Korn, Julianna T.D. Ross, Harshil Dhruv, Kristen M. Foss, Zita A. Sibenaller, Timothy C. Ryken, Michael B. Gotway, Seungchan Kim, Glen J. Weiss
Cyhoeddwyd 2011Artigo -
5
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of <i>ARID1A</i> Mutant Cancers gan Patricia J. Keller, Elizabeth J. Adams, Rentian Wu, Alexandre Côté, Shilpi Arora, Nico Cantone, Rosana Meyer, Jennifer A. Mertz, Victor Gehling, Jike Cui, Jacob I. Stuckey, Avinash Khanna, Feng Zhao, Zehua Chen, Ziyang Yu, Richard Cummings, Mohammed Taimi, Nehal J. Lakhani, Drew Rasco, Martin Gutierrez, Linda Duska, Michael Devitt, Ronda Rippley, Julian Levell, Jennifer Truong, Jing Wang, Kaiming Sun, Patrick Trojer
Cyhoeddwyd 2024Artigo -
6
Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target gan Laura A. Marlow, Jaclyn D'Innocenzi, Yilin Zhang, Stephen D. Rohl, Simon Cooper, Thomas Sebo, Clive S. Grant, Bryan McIver, Jan L. Kasperbauer, J. Trad Wadsworth, John D. Casler, Pamela W. Kennedy, W. Edward Highsmith, Orlo H. Clark, Dragana Milosevic, Brian C. Netzel, Kendall W Cradic, Shilpi Arora, Christian Beaudry, Stefan K. Grebe, Marc L. Silverberg, David O. Azorsa, Robert C. Smallridge, John A. Copland
Cyhoeddwyd 2010Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Biology
Cancer research
Gene
Medicine
Internal medicine
Biochemistry
Cancer
Genetics
CHEK1
Cell cycle
Cell cycle checkpoint
Immunology
Kinase
Leukemia
Myeloid leukemia
Oncology
Pharmacology
RNA
RNA interference
A549 cell
ARID1A
Apoptosis
Cancer cell
Cell biology
Chromatin
Chromatin remodeling
Context (archaeology)
Cyclin-dependent kinase 1
Cytarabine
DNA repair